Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.

Item
http://www.wikidata.org/entity/Q48420952
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's diseaseUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.Complement component C3 and butyrylcholinesterase activity are associated with neurodegeneration and clinical disability in multiple sclerosis.Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysisNovel ligands of Choline Acetyltransferase designed by in silico molecular docking, hologram QSAR and lead optimizationA review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.Fibrillar β-amyloid 1-42 alters cytokine secretion, cholinergic signalling and neuronal differentiation.Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening.Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.Cholinesterase activity in brain of senescence-accelerated-resistant mouse SAMR1 and its variation in brain of senescence-accelerated-prone mouse SAMP8.A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety.
P2860

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.

Item
http://www.wikidata.org/entity/Q48420952
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@en
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@nl
type
label
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@en
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@nl
prefLabel
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@en
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Differential CSF butyrylcholin ...... d cerebral glucose metabolism.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921